BioNTech aims to develop the first mRNA malaria vaccine as well as the capacity to produce it in Africa

BioNTech aims to develop the first mRNA malaria vaccine as well as the capacity to produce it in Africa

On the continent, the manufacturing facility will likely be located in South Africa, where last month, the WHO, Africa CDC and other partners established their first Covid-19 mRNA vaccine technology transfer hub.